↓
 

ParagraphFour.com

Pharmaceutical Patent Database

ParagraphFour.com
  • Home
  • About
  • Paragraph IV Explained
  • FAQ & Terms
  • The PIV Blog
  • PIV Data
    • Get Access
Home→parryashford

parryashford

Profile picture of parryashford

@parryashford

active 2 days, 16 hours ago
  • Home
  • Activity
  • Profile
  • Forums
  • Personal
  • Mentions
  • Favorites

Member Activities

RSS

Loading the member’s updates. Please wait.

Latest updates

The Paragraph Four Report®
Paragraph IV Activity for November 2019

New Certifications as reported by FDA on November 5 and 19, 2019

1. Vraylar®(cariprazine) Capsules 1.5mg, 3mg, 4.5mg, and 6mg on 9/17/2019
2. Tasigna®(nilotinib) Capsules 50mg on 10/17/2019
3. Protonix®(pantoprazole) Delayed-release Oral Suspension 40mg on 9/1…[Read more]

Profile picture of parryashford 1 week, 1 day ago

Desyrel®(trazodone) Tablets
Annual Sales N/A
Company PRAGMA PHARMACEUTICALS
Date of First Filing Not yet reported by FDA (see Special Note below)

Paragraph IV Applicant: Aurobindo
Case Name: AZIENDE CHIMICHE RIUNITE ANGELINI FRANCESCO ACRAFSPA v. AUROBINDO PHARMA USA INC.
Court/Case #: Delaware District Court (dedc)…[Read more]

Profile picture of parryashford 1 week, 2 days ago

Lenvima®(lenvatinib) Capsules
Annual Sales 37B JPY
Company EISAI
Date of First Filing February 13, 2019

Paragraph IV Applicant: Shilpa
Case Name: EISAI R&D MANAGEMENT CO LTD et al v. SHILPA MEDICARE LIMITED njdc
Court/Case #: New Jersey District Court (njdc) 3:2019cv19998
Date Filed: 11/8/19
Judge: Wolfson
Product…[Read more]

Profile picture of parryashford 3 weeks, 5 days ago
The Paragraph Four Report®, ParagraphFour.com® and the PFOUR logo are registered trademarks of Parry Ashford Inc. • ©Parry Ashford Inc. 2019
↑